259 related articles for article (PubMed ID: 25444820)
1. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.
Deshmukh AA; Chiao EY; Das P; Cantor SB
Vaccine; 2014 Dec; 32(51):6941-6947. PubMed ID: 25444820
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
Deshmukh AA; Chhatwal J; Chiao EY; Nyitray AG; Das P; Cantor SB
Clin Infect Dis; 2015 Nov; 61(10):1527-35. PubMed ID: 26223993
[TBL] [Abstract][Full Text] [Related]
3. Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
Deshmukh AA; Chiao EY; Cantor SB; Stier EA; Goldstone SE; Nyitray AG; Wilkin T; Wang X; Chhatwal J
Cancer; 2017 Dec; 123(23):4709-4719. PubMed ID: 28950043
[TBL] [Abstract][Full Text] [Related]
4. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
Swedish KA; Factor SH; Goldstone SE
Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant HPV vaccination for anal cancer prevention in HIV-positive men who have sex with men: The time is now.
Deshmukh AA; Cantor SB; Fenwick E; Chiao EY; Nyitray AG; Stier EA; Goldstone SE; Wilkin T; Chhatwal J
Vaccine; 2017 Sep; 35(38):5102-5109. PubMed ID: 28807605
[TBL] [Abstract][Full Text] [Related]
6. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
[TBL] [Abstract][Full Text] [Related]
7. HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+ MSM.
Gosens KCM; van der Zee RP; van Heukelom MLS; Jongen VW; Cairo I; van Eeden A; van Noesel CJM; Quint WGV; Pasmans H; Dijkgraaf MGW; de Vries HJC; Prins JM
AIDS; 2021 Sep; 35(11):1753-1764. PubMed ID: 33966029
[TBL] [Abstract][Full Text] [Related]
8. High-grade anal intraepithelial neoplasia among HIV-1-infected men screening for a multicenter clinical trial of a human papillomavirus vaccine.
Wilkin T; Lee JY; Lensing SY; Stier EA; Goldstone SE; Berry MJ; Jay N; Aboulafia DM; Einstein MH; Saah A; Mitsuyasu RT; Palefsky JM
HIV Clin Trials; 2013; 14(2):75-9. PubMed ID: 23611828
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.
Li Y; Lin YF; Wu X; Zhou X; Tian T; Guo Z; Fu L; Yang L; Lu Z; Fan S; Lu Y; Ke W; Zou H
Front Immunol; 2023; 14():1197191. PubMed ID: 37426648
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.
Sahasrabuddhe VV; Castle PE; Follansbee S; Borgonovo S; Tokugawa D; Schwartz LM; Lorey TS; LaMere BJ; Gage JC; Fetterman B; Boyle S; Sadorra M; Tang SD; Darragh TM; Wentzensen N
J Infect Dis; 2013 Feb; 207(3):392-401. PubMed ID: 23162133
[TBL] [Abstract][Full Text] [Related]
13. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis.
Kim JJ
Lancet Infect Dis; 2010 Dec; 10(12):845-52. PubMed ID: 21051295
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
15. Clinical Inquiry: Does qHPV vaccine prevent anal intraepithelial neoplasia and condylomata in men?
Shum J; Kelsberg G; Safranek S
J Fam Pract; 2015 Sep; 64(9):581-3. PubMed ID: 26546954
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patients.
Assoumou SA; Mayer KH; Panther L; Linas BP; Kim J
Sex Transm Dis; 2013 Apr; 40(4):298-303. PubMed ID: 23486494
[TBL] [Abstract][Full Text] [Related]
18. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile.
Vargas Parada C; Lennert Veerman J
Value Health Reg Issues; 2016 Dec; 11():17-23. PubMed ID: 27986194
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic HPV vaccination and anal cancer.
Stier EA; Chigurupati NL; Fung L
Hum Vaccin Immunother; 2016 Jun; 12(6):1348-51. PubMed ID: 26933898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
